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Abstract
The European Organisation for External Quality Assurance Providers in Laboratory Medicine (EQALM) was founded in 1996 and currently has mem-
bers from 29 European countries and 6 countries from outside Europe. EQALM provides a forum for co-operation and exchange of knowledge on 
quality-related matters in laboratory medicine, especially with regard to external quality assessment (EQA) programs in Europe. In addition, EQALM 
represent the EQA providers in laboratory medicine at European level vis-à-vis political, professional, scientific and other bodies, including patients’ 
organisations. To this end EQALM promotes activities such as organizing meetings with scientific and practical themes for members and other in-
terested parties, issuing scientific publications, developing EQA projects and representing laboratory medicine EQA activities within other organi-
sations and networks. EQALM is active in scientific and educational activity in different fields such as survey frequency, haematology, haemostasis, 
microbiology, nomenclature, virtual microscopy, traceability, accreditation, and quality assurance of the total testing process. The aim of this paper 
is to give an overview of the EQALM organisation.
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Introduction
The medical laboratories play an important role in 
diagnosis, treatment and follow-up of patients (1). 
It is important that the laboratories produce high 
quality test results as they often are basis for clini-
cal decision making (2). Proper quality manage-
ment is therefore essential. Medical laboratories 
have internal quality control procedures and par-
ticipate in national and/or international external 
quality assessment (EQA) programs. The EQA pro-
grams should be fit-for purpose (3) and should in-
clude the total testing process; the pre-analytical, 
analytical and post-analytical phase (4). Many EQA 
organizers provides programs for all these phases 
but there is a wide variation in how these pro-
grams are organized. It is therefore important for 
the EQA organizers that there is a forum in which 
they can share knowledge and co-operate to con-
stantly improve the EQA schemes.
The objective of the European Organisation for Ex-
ternal Quality Assurance Providers in Laboratory 
Medicine (EQALM) is to provide a forum for co-op-
eration and exchange of knowledge on quality-re-
lated matters, especially with regard to EQA pro-
grams in Europe; to promote the quality of labora-
tory medicine and the safety of patient care in 
general and in particular within Europe; and to 
represent the EQA providers in laboratory medi-
cine at European level vis-à-vis political, profes-
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sional, scientific and other bodies, including pa-
tients’ organisations. To this end EQALM promotes 
activities such as, but not limited to, organizing 
meetings with scientific and practical themes for 
members and other interested parties, issuing sci-
entific publications, developing EQA projects, 
maintaining the EQALM website, and representing 
laboratory medicine EQA activities within other or-
ganisations and networks. The aim of this paper is 
to give an overview of the EQALM organisation.
History - the foundation of EQALM
The initial meeting of European EQA organizers 
was conducted at the 8th European Congress of 
Clinical Chemistry in June 1989, Milan, Italy. Here a 
plan for further collaboration was established and 
in December of the same year, a meeting of 23 Eu-
ropean EQA organizers was held in Brussels in con-
junction with a meeting on reference methods 
and reference materials, organized by the Europe-
an Union agency Community Bureau of Reference 
(BCR). This was the first meeting between the EQA 
organizers involved in biochemistry and endocri-
nology. Later on there were also meetings in hae-
matology and microbiology. With exception of the 
first group, there were no long-term outcome ef-
fects from these meetings. In January 1990, the bi-
ochemistry and hormone group had started with 
a newsletter called “EQAnews” and with informal 
meetings at international and national congresses.
At the 9th European Congress of Clinical Chemistry 
in Cracow in 1991, Adam Uldall (Denmark) took the 
initiative to create three working groups (WG) on 
EQA related issues: 1) WG A on performance stand-
ards in EQA, 2) WG B on target values in EQA, and 
3) WG C on control materials in EQA. These WGs 
published nine scientific papers in the European 
Journal of Clinical Chemistry and Laboratory Medi-
cine (5-13). These papers are trend-setting publica-
tions in the field of clinical chemistry EQA. They 
were also published as the February issue of 
EQAnews in 2000.
The informal collaboration between European 
EQA organizers was formalized in 1996 in Pont à 
Mousson, France, having the inaugural meeting 
with the foundation of EQALM.
The EQALM office and executive board
EQALM is managed by an executive board of five 
to nine members from different EQA organisations 
and reflects the overall membership of EQALM. 
The board members are elected by the EQALM full 
members and are appointed for a term of three 
years with possibility to be re-elected for one 
more term. The registered office is in Geneva, 
Switzerland. The EQALM association is itself a legal 
entity and is registered with the Register of Com-
merce in Geneva. The structure of EQALM is shown 
in Figure 1.
Membership
EQA organisations can apply to be a full member 
(European) or non-European member if they are 
an impartial and non-profit EQA provider, which 
organizes national, regional or international EQA 
schemes in laboratory medicine. Individuals with 
an interest in EQA can become an individual mem-
ber. Commercial providers of EQA in laboratory 
medicine or other commercial companies with an 
interest in this field can support EQALM as associ-
ate members. Only full European members have 
the right to vote at the annual General Assembly. 
EQALM is currently gathering 49 EQA organisa-
tions from 29 European countries and 6 countries 
from outside Europe (Australia, Brazil, Canada, In-
dia, Sultanate of Oman and Taiwan).
EQALM aims to represent as most as possible dif-
ferent analytical domains in laboratory medicine. 
This includes, but is not limited to, clinical chemis-
try, haematology, haemostasis, microbiology, hor-
monology, immunology, parasitology, genetics, 
histopathology, dermatology and urinary analysis.
EQALM Symposium
Exchange of information between EQA organisers 
is one of the major objectives of EQALM. There-
fore, since the start in 1996, EQALM has organized 
annual meetings that gives members as well as 
non-members the opportunity to meet and ex-
change knowledge on EQA topics. In this way, val-
uable responses to EQA organisation’s daily ques-
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tions and practical feedback can be obtained on 
subjects such as implementation of the ISO 17043 
standard “Conformity assessment — General re-
quirements for proficiency testing” (14), harmoniza-
tion of laboratory methods, or statistics. Members 
are encouraged to share with the other organisa-
tions its experience and developments. Most of 
the presentations of the former symposiums are 
available on the EQALM website (15). Together 
with the annual symposium, meetings of the 
working groups are organised (see below) as well 
as the EQALM General Assembly.
Adam Uldall Award
In 2009 the Adam Uldall award was established in 
order to honour the founder of EQALM. The award 
is given during the annual symposium and goes to 
a person who has spent much of his/her career 
pursuing better quality across laboratory medi-
cine and who is a well-known and respected inter-
national advocate on quality. The former award 
winners are Jean-Claude Libeer (2009), Gunnar 
Nordin (2010), Andre Deom (2011), Carmen Ricos 
(2012), Dietmar Stockl and Linda Thienpont (2013), 
David Bullock (2014), Sverre Sandberg (2015) and 
Per Hyltoft Petersen (2016).
Working groups, scientific activities
Within the framework of EQALM several working 
groups are established. A working group consist of 
a number of EQALM members or third parties with 
a common interest in topics addressing scientific 
or educational EQA issues. The main objective is to 
federate the knowledge, experience and develop-
ment efforts on topics which are of interest for the 
members. In order to improve the scientific activi-
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ty of the working groups and to improve the inter-
action between the executive board and the work-
ing group chairs, a scientific committee was estab-
lished in 2016 (Figure 1). There are currently 6 ac-
tive working groups; frequency, haematology, 
haemostasis, microbiology, nomenclature and vir-
tual microscopy. 
Frequency
There is little published evidence of an optimal 
model for determining frequency of EQA surveys 
both in terms of distributions per year and num-
ber of samples per distribution, or on the relation-
ship between frequency and outcomes. The Fre-
quency working group was created as a result of a 
questionnaire distributed in 2008, which showed 
wide variation in practice even within the same 
speciality. The group had its first meeting in 2009 
and the main objective is to review the literature 
and existing data from EQA providers to provide 
guidance on the frequency of EQA surveys. The 
work streams focus on: 1) whether there is evi-
dence to determine whether greater frequency 
leads to improved performance, 2) gather evi-
dence as to whether multiple samples are more ef-
fective than single or few samples and 3) ultimate-
ly provide guidance to EQA providers on evidence 
based models for EQA design.
Haematology
The working group on Haematology was estab-
lished in 1998 and has focused on several topics 
over the years. They have published guidelines for 
setting up EQA schemes for blood smear interpre-
tation, including staining procedure, survey prepa-
ration, statistical evaluation and reporting (16,17), 
and compared evaluation procedures used by 
EQA providers for haemoglobin and leukocyte 
concentration (18). Based on the results from the 
latter study which showed wide variation in evalu-
ation procedures, the Haematology working 
group decided to propose state-of-the-art perfor-
mance specifications for automated blood cell 
counting. In 2013, more than 422,000 data from 
different EQA providers was collected and after 3 
years of statistical analysis and discussions, the 
working group is now able to proposed concen-
tration-dependent performance specifications for 
each biological parameter (publication in prepara-
tion). 
The Haematology working group has also devel-
oped a post-analytical EQA scheme where the par-
ticipating laboratories received a case history with 
questions about the blood cell counts and graphs 
obtained with their type of haematology equip-
ment. The objective was to assess the laboratories’ 
ability to adequately analyse pathological rates 
and alarms, to decide what additional analyses 
that needs to be performed in different clinical sit-
uations, and to make the necessary arrangements 
to inform the clinician. The scheme showed that 
the answers were notably depended on the par-
ticipants’ education level, which differs between 
countries. This post-analytical EQA scheme was or-
ganised by Noklus in the period 2010 – 2014 in 
which more than 10 European countries partici-
pated. Current projects in the working group of 
Haematology are harmonization of evaluation cri-
teria for manual blood cell counting (including 
commentaries on morphology and diagnosis) 
used in European EQA schemes, and to investigate 
the European practice of assessing performance in 
the haemoglobinopathies.
Haemostasis
The working group of Haemostasis was created in 
2004 and focuses on specific matters related to 
EQA in blood coagulation. As an example, it has 
been investigated which countries provide EQA 
for point-of-care (POC) international normalized 
ratio (INR) and how these schemes are organized 
(19). This study showed that only 12 EQA organiz-
ers from 9 countries provided an EQA for POC INR 
testing and that there was a wide variation in how 
these schemes were organized (e.g. survey fre-
quency, acceptability limits and type of control 
materials used). Another project is the stability of 
reconstituted quality control samples used in EQA 
survey for blood coagulation. The report of this 
project is available at the EQALM website (15). In 
2014, the working group of Haemostasis per-
formed a survey of pre-analytical routines for co-
agulation testing among 28 European countries 
(662 laboratories). The survey showed that there 
were different routines both between and within 
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countries, and that there is a need for harmonisa-
tion (publication in preparation). Because EQA or-
ganisations from all over Europe participate in this 
working group it has been able to set up a com-
parative study on between-laboratory variation 
and the effect of local calibration for the measure-
ment of INR based on the Quick and Owren test 
principles. In this study it was shown that the be-
tween laboratory variation is significant lower for 
Owren methods in comparison to Quick methods, 
but this difference disappear when users of Quick 
methods perform local calibration of their reagent 
(publication in preparation). The working group of 
Haemostasis investigated also the differences in 
the statistical methods used by different EQA or-
ganisations and the effect on the assessment of 
participant performance (publication in prepara-
tion). Currently the working group is focussing on 
quality assurance for POC devices.
Microbiology
The Microbiology working group has performed 
several projects and surveys since the start in 
2003. An early survey on Microbiology EQA prac-
tices found that only a limited number of EQA or-
ganisers produced their own EQA samples, but 
those who did performed some kind of homoge-
neity and stability testing before distributing the 
samples, which differed from one organizer to an-
other. Importantly, this survey was done prior to 
the publication and general adoption of ISO 17043 
(14); practices may therefore be different today. 
Other findings were that the majority of laborato-
ries use antimicrobial susceptibility guidelines pro-
duced by either the Clinical and Laboratory Stand-
ards Institute (CLSI) (20) or the European Commit-
tee on Antimicrobial Susceptibility Testing (EU-
CAST) (21) with country or regional guideline pref-
erences not based on accreditation requirement. 
EQA organizers providing samples for blood para-
site analysis reported they prepared their blood 
smear samples manually. Reports and presenta-
tions from the different projects are available on 
the EQALM web site (15). A study from 2008 com-
paring the results from an EQA concerning Strepto-
coccus pyogenes from Canada and Belgium showed 
that the microbiology laboratories performed well 
in both countries but there were differences be-
tween laboratories in treating EQA samples and 
reporting results (22). Based on the results of a 
more current survey performed in 2015 on on-go-
ing and future objectives for the EQALM Microbi-
ology working group (15), the EQA organizers (N = 
29) identified three major objectives: 1) present 
new or novel activities or projects that might en-
hance microbiology EQA, 2) discuss topics, such as 
changing international regulations, that could po-
tentially impact on the delivery of microbiology 
EQA products and/or services, and 3) discuss pos-
sible shared microbiology EQA projects (e.g. on 
sample commutability and antimicrobial multi-re-
sistance in bacteria). Plans for new projects in the 
domain of susceptibility testing and antibiotic re-
sistance are in development.
Nomenclature
This working group was formed in 2003 with the 
objective of creating a database, which could be 
used by all EQALM members to assist in uniquely 
identifying analytical systems that were used 
across Europe. Though on the surface this might 
seem to be a straightforward task, the main diffi-
culty was that many products were re-badged by 
local distributors and that often the same product 
could have subtly different versions that were on 
sale in different countries. The rationale for the da-
tabase was to ensure comparability of coding by 
EQA Schemes to assist in the vigilance function 
that the In Vitro Diagnostic (IVD) Directive 98/79/
EC required. Essentially this was to make sure that 
when the performance of a product or instrument 
was highlighted as having potential problems, all 
EQALM members would be able to assess if that 
product was causing problems in their jurisdiction 
irrespective of what name the instrument was sold 
under. The group has tried to widen its scope from 
its Haematology starting point into Chemistry 
where the same issues exist, but the situation is 
more complex in the way that combinations of in-
struments, reagents and calibrators are used by 
laboratories.
Virtual microscopy
The main objectives of this working group is to 
promote the use of virtual microscopy (VM) in the 
EQA domain and to establish a framework for the 
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collaboration and exchanges between EQALM 
members. The VM working group had its first 
meeting in 2006. The first action was to identify 
the EQA domains in laboratory medicine, which 
could benefit from this new technology, and to 
identify the EQA providers of VM schemes. The re-
sults showed that the EQA domains mainly con-
cerned histopathology and haematology on blood 
smear and bone marrow but an interest was also 
identified for urine analysis and parasitology. At 
that time, EQA VM schemes were proposed by 
eight organisations using heterogeneous plat-
forms and software making exchanges between 
organisations very difficult.
The current activities of this group are focused on 
the creation of an EQALM VM Sharing Platform for 
sharing VM resources (e.g. scanning, virtual slides, 
educational contents, surveys, evaluation, and ex-
pertise) contributed by EQALM members in a way 
that is available, beneficial for all, and compatible 
with the existing VM solutions. It is based on web 
technologies for an easy and effective use even 
with limited computing resources. The establish-
ment of standards for resources and exchange 
protocols is also key point for the success of this 
project. The progress of the work of the VM work-
ing group demonstrates the catalytic and support-
ing role of EQALM.
Cooperation with other organisations
EQALM is active in different networks and work to-
gether with other organisations. In the European 
Federation of Clinical Chemistry and Laboratory 
Medicine (EFLM), EQALM has two representatives 
in the working group on pre-analytical phase (WG-
PRE) and post-analytical phase (WG-POST). The 
WG-POST is a joint working group between EQALM 
and EFLM and has recently published two papers. 
One of the papers was an international study on 
how laboratories handle and evaluate patient sam-
ples after detecting an unexpected Activated Par-
tial Thromboplastin Time (APTT) prolongation (23). 
The study showed that many laboratory profes-
sionals were not able to support clinicians appro-
priately in the interpretation of an unexpected pro-
longed APTT. The second paper investigated if D-
dimer is used according to clinical algorithms in the 
diagnostic work-up of patients with suspicion of 
venous thromboembolism (24). It showed that ad-
herence to recommendations for the diagnosis of 
venous thromboembolism needs improvement.
Further, EQALM is an associate member of Eura-
chem, EuroLab and the European Accreditation 
(EEE) and has three representatives in the Eura-
chem Proficiency Testing working group and in 
the EEE Proficiency Testing Working Group “Profi-
ciency Testing in Accreditation”. All EQALM repre-
sentatives must give a brief annual written activity 
report to the executive board.
EQALM also co-operate with the Joint Committee 
for Traceability in Laboratory Medicine (JCTLM) 
which has one working group on traceability and 
one on reference materials, procedures and meas-
urement laboratories (the JCTLM Database work-
ing group), and has also participated in the harmo-
nization working group of the American Associa-
tion for Clinical Chemistry (AACC) which resulted 
in a roadmap of harmonization of clinical labora-
tory measurement procedures (25).
Conclusion
The EQALM organisation provides an important 
forum for EQA providers in exchanging knowl-
edge and experience on quality matters in the 
field of laboratory medicine in Europe. Important 
scientific and educational activity are performed 
in different fields such as survey frequency, hae-
matology, haemostasis, microbiology, nomencla-
ture, virtual microscopy, traceability, accreditation, 
and quality assurance of the total testing process. 
One important future question is whether EQALM 
should expand out of Europe and become a world-
wide organisation.
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